Literature DB >> 21830402

Helicobacter pylori upregulates the expression of p16(INK4) in gastric cancer cells.

Ping Wang1, Juan Mei, Ning Zhang, Jing Tao, Hua Tian, Guo-Hui Fu.   

Abstract

BACKGROUND/AIMS: Previous studies have suggested that p16(INK4) protein is over expressed in gastric cancer. However, whether H. pylori infection induces p16(INK4) in human gastric epithelial cells remains to be determined. The aim of this study was to analyze the molecular mechanism of H. pylori-induced p16(INK4) expression.
METHODOLOGY: Expression of p16(INK4) mRNA and Sp1 mRNA were assessed by reverse transcription-PCR. Expression of p16(INK4) protein was assessed by Western blot and immunocytochemistry. A luciferase assay was used to monitor activation of the p16(INK4) gene promoter and to explore the binding of transcription factors to this promoter.
RESULTS: H. pylori upregulates the expression of p16(INK4) in gastric cancer SGC7901 cells. p16 promoter is highly actived in SGC7901 cells by H. pylori. Sp1 activates the expression of p16(INK4)-Luc and promotes the protein level of p16(INK4).
CONCLUSION: H. pylori upregulates the expression of p16(INK4) in gastric cancer SGC7901 cells via the p16(INK4) promoter, and Sp1 is involved in the activation of p16(INK4) promoter by H. pylori.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21830402

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  2 in total

1.  Characterization of oncogene suppressor marker expression in patients with submucosal gastric carcinoma.

Authors:  Roberson A Moron; Carlos Eduardo Jacob; Claudio José Caldas Bresciani; Kleber Simões; Venâncio Avancini Ferreira Alves; Kyoshi Irya; Joaquim Gama-Rodrigues; Ivan Cecconello; Adhemar Longatto-Filho; Bruno Zilberstein
Journal:  Mol Clin Oncol       Date:  2017-12-29

2.  Risk assessment of mouse gastric tissue cancer induced by dichlorvos and dimethoate.

Authors:  Qing-Lu Wang; Yu-Jun Zhang; Cai-Xia Zhou; Jie Zhang; Ye Dou; Qiao-Qiao Li
Journal:  Oncol Lett       Date:  2013-01-28       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.